scholarly journals Inhibitory Effect of Silodosin, Tamsulosinand Terazosin in Phenylephrine Induced-Prostate Smooth Muscle Contraction (a Comparative in vitro Study)

Author(s):  
Besut Daryanto
1996 ◽  
Vol 319 (2) ◽  
pp. 551-558 ◽  
Author(s):  
Yoshiaki UYAMA ◽  
Yuji IMAIZUMI ◽  
Minoru WATANABE ◽  
Michael P. WALSH

α-Calponin is a thin-filament-associated protein which has been implicated in the regulation of smooth muscle contraction. Quantification of the tissue content of rat tail arterial smooth muscle revealed approximately half the amount of α-calponin relative to actin compared with chicken gizzard and other smooth muscles, suggesting that this tissue would be particularly suitable for investigation of the effects of exogenous α-calponin on the contractile properties of permeabilized muscle strips. Rat tail arterial strips demembranated with Triton X-100 retained ≈ 90% of their complement of α-calponin, and exogenous chicken gizzard α-calponin (which conveniently has a slightly lower molecular mass than the rat arterial protein) bound to the permeabilized muscle, presumably through its high affinity for actin. Exogenous α-calponin inhibited force in demembranated muscle strips in a concentration-dependent manner when added at the peak of a submaximal Ca2+-induced contraction, with a half-maximal effect at ≈ 3 µM α-calponin. Pretreatment of demembranated muscle strips with α-calponin inhibited subsequent force development at all concentrations of Ca2+ examined over the activation range. The inhibitory effect of α-calponin was shown to be Ca2+-independent, since exogenous α-calponin also inhibited force in the absence of Ca2+ in demembranated muscle strips containing thiophosphorylated myosin. Phosphorylation of α-calponin on Ser-175 by protein kinase C has been suggested to alleviate the inhibitory effect of α-calponin on smooth muscle contraction. To test this hypothesis, the effects on Ca2+-induced and Ca2+-independent contractions of demembranated muscle strips of phosphorylated α-calponin and three site-specific mutants of α-calponin (in which Ser-175 was replaced by Ala, Asp or Thr) were compared with the effects of unphosphorylated tissue-purified and recombinant wild-type α-calponins. The recombinant wild-type protein behaved identically to the unphosphorylated tissue-purified protein, as did the S175T mutant, which is known to bind actin with high affinity and to inhibit the actin-activated myosin MgATPase in vitro. On the other hand, phosphorylated α-calponin and the S175A and S175D mutants, which bind weakly to actin and have little effect on the actin-activated myosin MgATPase in vitro, failed to cause significant inhibition of force induced by Ca2+ or myosin thiophosphorylation. These results support a role for α-calponin in the regulation of smooth muscle contraction and indicate the functional importance of Ser-175 of α-calponin as a regulatory site of phosphorylation.


1998 ◽  
Vol 85 (4) ◽  
pp. 1464-1470 ◽  
Author(s):  
Norihiro Shinozuka ◽  
Jean-Pierre Lavoie ◽  
James G. Martin ◽  
Jason H. T. Bates

It is well established that the degree of airway smooth muscle shortening produced by a given dose of bronchial agonist is greatly affected by lung volume. The airways are tethered by parenchymal attachments, the tension of which increases progressively with lung volume, thereby presenting a commensurately increasing hindrance to smooth muscle contraction. Earlier studies (P. F. Dillon, M. O. Aksoy, S. P. Driska, and R. A. Murphy. Science 211: 495–497, 1981) presented evidence that smooth muscle contraction initially involves rapidly cycling cross bridges, which then change to noncycling (latch) bridges. They also suggested that most of the muscle shortening occurs during the early rapid cross-bridge phase. This implies that smooth muscle subject to a given load early in contraction should shorten less than when it is subject to the same load later on. An in vitro study (W. Li and N. L. Stephens. Can. J. Physiol. Pharmacol. 72: 1458–1463, 1994) obtained support for this notion. To test this hypothesis in vivo, we measured the changes in lung impedance at 1 and 6 Hz produced in dogs by a bolus intravenous injection of methacholine when lung volume was increased for 10 s at different times after injection. We found that the changes in mechanics were greatly inhibited, whereas lung volume was elevated. However, when lung volume was returned to its initial level, the lung mechanics continued to change at a rate unaffected by the preceding volume change. We conclude that temporary mechanical inhibition of airway smooth muscle shortening in the normal dog in vivo merely delays an otherwise normal course of contraction.


2021 ◽  
Vol 16 (1) ◽  
pp. 208-213
Author(s):  
Sahar Khunkar ◽  
Ilnaz Hariri ◽  
Ehab Alsayed ◽  
Amal Linjawi ◽  
Sawsan Khunkar ◽  
...  

2010 ◽  
Vol 9 (6) ◽  
pp. 619
Author(s):  
G.T. Kedia ◽  
S. Ückert ◽  
M. Kedia ◽  
L. Managadze ◽  
M.A. Kuczyk

1994 ◽  
Vol 266 (3) ◽  
pp. H898-H902 ◽  
Author(s):  
F. Ohkawa ◽  
U. Ikeda ◽  
K. Kawasaki ◽  
E. Kusano ◽  
M. Igarashi ◽  
...  

Our objective was to investigate the direct effect of interleukin-6 (IL-6) on the vascular smooth muscle contraction. We measured the contraction of endothelium-denuded aortic rings isolated from Sprague-Dawley rats. We also investigated the involvement of vasodilator prostaglandin and guanosine 3',5'-cyclic monophosphate (cGMP) productions in the effect of IL-6 using cultured rat vascular smooth muscle cells (VSMC). Exposing the aortic rings to recombinant murine IL-6 (50 U/ml) for 180 min significantly suppressed the phenylephrine (10(-9)-10(-5) M)-induced contraction. This inhibitory effect of IL-6 on the contraction tended to exhibit a dose-dependent relationship (0.5-50 U/ml). The effect of IL-6 was totally eliminated in the presence of indomethacin (10(-5) M). The release of immunoreactive 6-ketoprostaglandin F1 alpha from cultured rat VSMC was significantly increased by exposure to IL-6. Intracellular cGMP concentration in VSMC was not affected by IL-6. In conclusion, IL-6 is a potent inhibitor of the alpha-adrenergic-stimulated contraction of vascular smooth muscle. Its action is endothelium independent and mediated by the increased synthesis of prostacyclin in VSMC.


Urology ◽  
1990 ◽  
Vol 36 (2) ◽  
pp. 193-198 ◽  
Author(s):  
Alex E. Finkbeiner ◽  
Pat D. O'Donnell

2001 ◽  
Vol 73 (3) ◽  
pp. 381-384 ◽  
Author(s):  
Shahina Naz ◽  
Rahmanullah Siddiqi ◽  
Syed Asad Sayeed

Sign in / Sign up

Export Citation Format

Share Document